...
首页> 外文期刊>Clinical advances in hematology & oncology: H&O >EGFR Inhibition in Colorectal Cancer With Liver Metastasis
【24h】

EGFR Inhibition in Colorectal Cancer With Liver Metastasis

机译:EGFR抑制与肝转移的结肠直肠癌

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

H&O What is the standard course of treatment for patients with metastatic colorectal cancer that has spread to the liver? AG The first step in managing patients with metastatic colorectal cancer (CRC) who have liver-limited disease is a consultation with a dedicated liver surgeon to see whether the liver metastasis can be resected. After we know that, we can determine the appropriate treatment strategy. Can the liver metastasis be resected right away, do we need to induce an anatomical shrinkage of liver lesions in order to make them resectable, or do we have an unresectable palliative situation from the outset? The medical oncologist and the liver surgeon both need to evaluate the patient and work as a team.
机译:None

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号